Vyne Therap 
Welcome,         Profile    Billing    Logout  
  Products    Diseases   Products    Trials    News 
2 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
serlopitant (JTS 661) / Vyne Therap
2017-003250-16: A Study Of The Efficacy, Safety, And Tolerability Of Serlopitant For The Treatment Of Chronic Cough with No Apparent Cause

Not yet recruiting
2
170
Europe
Serlopitant, VPD-737, Film-coated tablet
Menlo Therapeutics Inc., Menlo Therapeutics Inc.
Refractory Chronic Cough, Chronic cough with no apparent cause, Diseases [C] - Respiratory Tract Diseases [C08]
 
 
repibresib (VYN201) / Vyne Therap
NCT06493578: A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of VYN201 Gel in Subjects With Non-segmental Vitiligo.

Active, not recruiting
2
200
Canada, US
VYN201 Gel, Vehicle Gel
Vyne Therapeutics Inc.
Non-segmental Vitiligo
06/25
01/26
VYN202 / Vyne Therap
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
serlopitant (JTS 661) / Vyne Therap
2017-003250-16: A Study Of The Efficacy, Safety, And Tolerability Of Serlopitant For The Treatment Of Chronic Cough with No Apparent Cause

Not yet recruiting
2
170
Europe
Serlopitant, VPD-737, Film-coated tablet
Menlo Therapeutics Inc., Menlo Therapeutics Inc.
Refractory Chronic Cough, Chronic cough with no apparent cause, Diseases [C] - Respiratory Tract Diseases [C08]
 
 
repibresib (VYN201) / Vyne Therap
NCT06493578: A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of VYN201 Gel in Subjects With Non-segmental Vitiligo.

Active, not recruiting
2
200
Canada, US
VYN201 Gel, Vehicle Gel
Vyne Therapeutics Inc.
Non-segmental Vitiligo
06/25
01/26
VYN202 / Vyne Therap
No trials found

Download Options